Sign inGet started

Cohen Kenneth M

Insider CIK 1346981 · MBVX Director · ADMP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2018-04-022018-04-03513— $00SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2018-04-022018-04-04513— $00SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2018-04-022018-04-03513— $026,808SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2018-04-022018-04-04513— $024,552SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2018-02-212018-02-2335,000— $035,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN S Sale2018-01-242018-01-2417,996$0.84 $15.1K78,355SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN S Sale2018-01-232018-01-2417,444$0.87 $15.2K96,351SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2018-01-082018-01-12100,000— $01,543SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2018-01-082018-01-12100,000— $0100,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-10-022017-10-0475,790— $075,790SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-09-152017-09-1824,210— $024,210SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-06-122017-06-1420,000$1.57 $31.4K20,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-05-192017-05-2350,000$1.80 $90.0K50,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2017-04-022017-04-041,543— $01,543SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2017-04-022017-04-041,543— $07,557SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-01-012017-01-034,100$3.38 $13.9K4,100SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2016-08-292016-08-304,100$5.00 $20.5K4,100SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy deriv2016-08-172016-08-193,119— $03,119SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy deriv2016-08-172016-08-193,119— $03,119SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy2016-08-172016-08-193,119— $06,014SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2016-06-292016-07-2835,000$0.55 $19.3K35,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2016-04-042016-04-0511,417— $022,833SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2016-04-042016-04-0511,417— $011,417SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2015-08-262015-08-2735,000$1.52 $53.2K35,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy2015-05-222015-05-263,500$2.30 $8.0K10,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2015-04-022015-04-0334,250— $034,250SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2015-04-022015-04-0334,250$2.30 $78.8K34,250SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy2014-12-172014-12-182,500$1.80 $4.5K17,616SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN P Buy2014-12-162014-12-174,000$2.41 $9.6K15,116SEC↗
ADMP Adamis Pharmaceuticals Cor A Award deriv2013-10-162013-10-1735,000— $035,000SEC↗
ADMP Adamis Pharmaceuticals Cor A Award2013-03-062013-03-1219,776— $019,776SEC↗
ADMP Adamis Pharmaceuticals Cor A Award deriv2012-10-112012-10-1535,000— $035,000SEC↗